Vast Therapeutics, a clinical-stage life science company, today announced that the U.S. Food and Drug Administration has ...

The wave of melioidosis infections has been exacerbated by poverty and the increasing severity of storms and floods resulting ...

Rigorous testing demonstrates robust antimicrobial performance against bacterial strains relevant to cardiac implanted electronic device (CIED) ...

In this article, we discuss transformation, bacterial transformation in particular, and how scientists can utilize it to ...

An uncomplicated urinary tracti infection (UTI) could go away on its own, but waiting increases the risk of symptoms turning ...

Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical-stage biotechnology company pioneering innovative therapies for cancer and viral infections, announces that its chief medical officer, Roger ...

In a new paper, researchers describe the creation of synthetic peptides, a class of antibiotics, derived from the secretions ...

Antimicrobial resistance (AMR) is a critical global issue, contributing to increased morbidity and mortality, prolonged hospital ...

NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical-stage biotechnology company dedicated to developing novel treatments for cancer and viral infections ...

Burn victims are being treated at hospitals throughout Europe, and officials are urging proper precautions be taken to ...

A review and meta-analysis of four randomized controlled trials finds 7 days is noninferior to 14 days of antibiotics for ...